Universal Health (UHS) Reports In-Line Q4 EPS; offers guidance
Tweet
Share
E-mail
Get Alerts UHS Hot Sheet
Price: $169.65 +0.26%
EPS Growth %: -8.1%
Financial Fact:
Net income: 157.27M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -8.1%
Financial Fact:
Net income: 157.27M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Universal Health (NYSE: UHS) reported Q4 EPS of $5.88, in-line with the analyst estimate of $5.88. Revenue for the quarter came in at $4.49 billion, versus $4.51 billion reported last year.
GUIDANCE:
Universal Health sees FY2026 EPS of $22.64-$24.52, versus the consensus of $23.39. Universal Health sees FY2026 revenue of $18.417-18.789 billion, versus the consensus of $18.244 billion.
For earnings history and earnings-related data on Universal Health (UHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
